GSK

Q: What is the price of GlaxoSmithKline (GSK) today?

The price of GlaxoSmithKline (GSK) today is $ 50.22, with return of 55.17% compared to the last year. The price of GlaxoSmithKline (GSK) started the year trading around $ 49.04 and today it is at $ 50.22. Follow the real-time price chart, the historical price of GlaxoSmithKline (GSK) and international markets.

Q: When does GlaxoSmithKline (GSK) pay dividends?

In the last year, GlaxoSmithKline (GSK) distributed dividends in the month of January, totaling $ 0.41. The Dividend Yield for the last 12 months is 3.35%.

Q: Is GlaxoSmithKline (GSK) worth it?

Currently, GlaxoSmithKline (GSK) is priced at $ 50.22, with a P/E of 13.60%, representing a deviation of 1,211% from its historical average P/E. In the last year, the stock showed a variation of 55.17 in its price and distributed $ 0.41 in dividends, resulting in a Dividend Yield of 3.35%. The total shareholder return was 55.17%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy GlaxoSmithKline (GSK) stock?

Investing in stocks of GlaxoSmithKline (GSK) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of GlaxoSmithKline (GSK) yield today?

The yield of GlaxoSmithKline (GSK) was 7.15% in the last month, 55.17% in the last year and 110.15% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 1.67 in dividends, with a Dividend Yield of 3.35%.If you wanted to buy 100 stocks of GlaxoSmithKline (GSK) today, the total investment would be $ 5,022.00, based on the current price of $ 50.22.If past performance were to repeat, the return on your investment would be:In 1 year: $ 7,792.64In 5 years: $ 10,553.73In 10 years: $ 14,313.20It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GlaxoSmithKline PLC

Price

$ 50.22

return (12m)

55.17%

p/e

13.60

p/bv

4.66

DIVIDEND YIELD

3.35%

price GSK

GSK

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of GSK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

7.15%

3 months

16.33%

1 year

55.17%

2 years

38.26%

5 years

110.15%

10 years

185.01%

Fundamentals GSK

review the fundamentals of GlaxoSmithKline shares

P/E

13.60

Sector: -2.17 Industry: 7.15

P/SALES RATIO (PSR)

2.34

Sector: 2.09 Industry: 1.83

P/BV

4.66

Sector: 2.32 Industry: 3.14

DIVIDEND YIELD (DY)

3.35%

Sector: - Industry: 0.01%

ROA

8.81%

Sector: -27.11% Industry: 2.53%

ROE

34.29%

Sector: -30.07% Industry: 4.69%

ROIC

18.95%

Sector: -415.44% Industry: -4.33%

NET MARGIN

17.23%

Sector: -28.18% Industry: 1.02%

GROSS MARGIN

72.32%

Sector: 44.12% Industry: 25.64%

OPERATING MARGIN

23.59%

Sector: -24.28% Industry: 0.64%

P/EBITDA

6.65

Sector: -0.46 Industry: 2.64

P/EBIT

9.71

Sector: -2.78 Industry: 1.70

P/ASSET

1.20

Sector: 1.27 Industry: 1.52

BVPS

10.55

Sector: 3.36 Industry: 14.86

EPS

3.62

Sector: -0.89 Industry: 1.02

EQUITY RATIO

0.26

Sector: 0.43 Industry: 0.47

CAGR REVENUE 5 YEARS

2.75%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

5.39%

Sector: - Industry: -

FAIR VALUE OF GlaxoSmithKline ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 50.22

Fair Value

$ 0.00

Upside Return potential.

-41.63%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals GSK

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	52.63	40.63	77.20%	0.56%	$ 969.08 B	30.99%
ISRG	73.04	11.77	16.12%	0.00%	$ 200.63 B	28.58%
TMO	34.09	4.38	12.84%	0.28%	$ 223.97 B	15.02%
SNY	10.49	1.46	13.90%	4.59%	$ 118.21 B	14.83%
NVS	18.54	5.96	32.16%	2.79%	$ 266.83 B	25.53%
MDT	25.85	0.00	0.00%	2.94%	$ 123.14 B	13.71%
ABT	15.54	4.24	27.26%	1.89%	$ 217.16 B	31.88%
CVS	216.81	1.39	0.64%	3.32%	$ 101.68 B	0.12%
BSX	50.27	0.00	0.00%	0.00%	$ 140.36 B	14.43%
TMDX	45.46	11.74	25.84%	0.00%	$ 4.17 B	16.20%
HCA	17.28	-50.76	-293.84%	0.61%	$ 109.60 B	8.53%
IDXX	52.17	34.33	65.81%	0.00%	$ 53.60 B	24.65%
INMD	6.23	1.43	22.89%	0.00%	$ 932.40 M	41.04%
DHR	46.76	3.21	6.86%	0.53%	$ 163.81 B	14.43%
RMD	24.86	5.84	23.49%	0.92%	$ 35.74 B	27.35%
FMS	16.83	0.84	5.00%	3.35%	$ 13.73 B	3.73%
PHG	114.34	2.07	1.81%	3.27%	$ 25.75 B	1.14%
SYK	45.08	6.09	13.51%	0.97%	$ 132.67 B	12.07%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

GSK Historical Dividends

current DY: 3.35%

5-year average DY: 5.11%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	11/14/2025	01/08/2026	0,40960000
Dividend	08/15/2025	10/09/2025	0,42810000
Dividend	05/16/2025	07/10/2025	0,42910000
Dividend	02/21/2025	04/10/2025	0,40060000
Dividend	11/15/2024	01/09/2025	0,38900000
Dividend	08/16/2024	10/10/2024	0,38570000
Dividend	05/17/2024	07/11/2024	0,37620000
Dividend	02/23/2024	04/11/2024	0,40610000
Dividend	11/17/2023	01/11/2024	0,33980000
Dividend	08/18/2023	10/12/2023	0,36130000
Dividend	05/19/2023	07/13/2023	0,34750000
Dividend	02/24/2023	04/13/2023	0,34040000
Dividend	11/18/2022	01/12/2023	0,31710000
Dividend	08/19/2022	10/06/2022	0,39080000
Dividend	05/20/2022	07/01/2022	0,34960000
Dividend	02/25/2022	04/07/2022	0,62210000
Dividend	11/19/2021	01/13/2022	0,52340000
Dividend	08/20/2021	10/07/2021	0,53010000
Dividend	05/21/2021	07/08/2021	0,52700000
Dividend	02/19/2021	04/08/2021	0,63670000
Dividend	11/13/2020	01/14/2021	0,49600000
Dividend	08/14/2020	10/08/2020	0,49290000
Dividend	05/15/2020	07/09/2020	0,47390000
Dividend	02/21/2020	04/09/2020	0,59900000
Dividend	11/15/2019	01/09/2020	0,48900000
Dividend	08/09/2019	10/10/2019	0,46580000
Dividend	05/17/2019	07/11/2019	0,49530000
Dividend	02/22/2019	04/11/2019	0,60170000
Dividend	11/16/2018	01/10/2019	0,48380000
Dividend	08/10/2018	10/11/2018	0,50110000
Dividend	05/11/2018	07/12/2018	0,53000000
Dividend	02/23/2018	04/12/2018	0,63800000
Dividend	11/10/2017	01/11/2018	0,50400000
Dividend	08/11/2017	10/12/2017	0,50100000
Dividend	05/12/2017	07/13/2017	0,49040000
Dividend	02/24/2017	04/13/2017	0,57120000
Dividend	11/04/2016	01/12/2017	0,46210000
Dividend	08/12/2016	10/13/2016	0,49900000
Dividend	05/13/2016	07/14/2016	0,55400000
Dividend	02/19/2016	04/14/2016	1,25200000
Dividend	11/13/2015	01/14/2016	0,58200000
Dividend	08/14/2015	10/01/2015	0,59300000
Dividend	05/15/2015	07/09/2015	0,57790000
Dividend	02/20/2015	04/09/2015	0,68540000
Dividend	11/07/2014	01/08/2015	0,60440000
Dividend	08/08/2014	10/02/2014	0,63910000
Dividend	05/16/2014	07/10/2014	0,63100000
Dividend	02/21/2014	04/10/2014	0,75000000
Dividend	11/15/2013	01/09/2014	0,60740000
Dividend	08/09/2013	10/03/2013	0,54540000
Dividend	05/10/2013	07/11/2013	0,54250000
Dividend	02/22/2013	04/11/2013	0,67980000
Dividend	11/16/2012	01/03/2013	0,57080000
Dividend	08/10/2012	10/04/2012	0,52050000
Dividend	05/11/2012	07/05/2012	0,54140000
Dividend	02/17/2012	04/12/2012	0,82100000
Dividend	11/04/2011	01/05/2012	0,53350000
Dividend	08/05/2011	10/06/2011	0,51200000
Dividend	05/06/2011	07/07/2011	0,51710000
Dividend	02/11/2011	04/07/2011	0,61500000
Dividend	10/29/2010	01/06/2011	0,49850000
Dividend	07/30/2010	10/07/2010	0,44920000
Dividend	05/07/2010	07/08/2010	0,45230000
Dividend	02/12/2010	04/08/2010	0,57400000
Dividend	11/06/2009	01/07/2010	0,48140000
Dividend	07/31/2009	10/08/2009	0,45290000
Dividend	05/01/2009	07/09/2009	0,40210000
Dividend	02/13/2009	04/09/2009	0,48590000
Dividend	10/31/2008	01/08/2009	0,46650000
Dividend	08/01/2008	10/09/2008	0,51000000
Dividend	05/02/2008	07/10/2008	0,50950000
Dividend	02/15/2008	04/10/2008	0,62700000
Dividend	11/02/2007	01/10/2008	0,52320000
Dividend	08/03/2007	10/11/2007	0,48600000
Dividend	05/04/2007	07/12/2007	0,47220000
Dividend	02/16/2007	04/12/2007	0,55200000
Dividend	11/03/2006	01/04/2007	0,44260000
Dividend	08/04/2006	10/05/2006	0,39920000
Dividend	05/12/2006	07/06/2006	0,38630000
Dividend	02/17/2006	04/06/2006	0,47890000
Dividend	11/04/2005	01/05/2006	0,34900000
Dividend	08/05/2005	10/06/2005	0,34170000
Dividend	05/13/2005	07/07/2005	0,37340000
Dividend	02/18/2005	04/07/2005	0,43660000
Dividend	11/05/2004	01/06/2005	0,35880000
Dividend	08/06/2004	09/30/2004	0,35950000
Dividend	05/14/2004	07/01/2004	0,34660000
Dividend	02/20/2004	04/15/2004	0,51080000
Dividend	10/31/2003	01/06/2004	0,29490000
Dividend	08/01/2003	10/02/2003	0,28130000
Dividend	05/09/2003	07/03/2003	0,31700000
Dividend	02/21/2003	04/17/2003	0,45700000
Dividend	11/01/2002	01/03/2003	0,30260000
Dividend	08/02/2002	10/03/2002	0,30590000
Dividend	05/03/2002	07/05/2002	0,55500000
Dividend	02/22/2002	04/18/2002	0,71500000
Dividend	11/02/2001	01/03/2002	0,27930000
Dividend	08/03/2001	10/04/2001	0,27790000
Dividend	05/04/2001	07/05/2001	0,28230000
Dividend	12/26/2000	04/27/2001	0,74200000
Dividend	08/11/2000	10/26/2000	0,50200000
Dividend	03/03/2000	06/05/2000	0,78500000
Dividend	08/13/1999	10/12/1999	0,53970000
Dividend	03/05/1999	06/01/1999	0,59500000
Dividend	08/14/1998	10/13/1998	0,49980000
Dividend	03/06/1998	06/01/1998	0,65200000
Dividend	08/15/1997	12/02/1997	0,49100000
Dividend	03/21/1997	05/30/1997	0,72700000
Dividend	08/20/1996	10/11/1996	0,58400000
Dividend	03/26/1996	05/30/1996	0,58000000
Dividend	09/26/1995	11/02/1995	0,77400000
Dividend	03/02/1995	04/20/1995	0,38500000

ABOUT THE COMPANY GlaxoSmithKline

GlaxoSmithKline PLC

Average user rating I10

5.0 (73 people)

United States

27 years

Founded: 1999

1987

Time since IPO - 39 years

90.090

Employees

GlaxoSmithKline plc is a United Kingdom–based company operating in the healthcare sector, within the pharmaceutical and biotechnology industry. The company specializes in researching, developing and commercializing medicines, vaccines and health products aimed at preventing and treating a wide range of diseases.

It was established in 2000 through the merger of two major British companies — Glaxo Wellcome and SmithKline Beecham — in a strategic move to integrate complementary portfolios, expand scientific research capabilities and strengthen global competitiveness.

GSK’s portfolio includes innovative medicines in immunology, respiratory diseases, HIV, oncology and infectious diseases, as well as a broad range of vaccines used in public and private healthcare programs worldwide. The company also operates in consumer healthcare, though this area has undergone significant restructuring and partial separation in recent years.

GSK operates globally, maintaining a presence in more than one hundred countries, with research centers in Europe, North America and Asia, and manufacturing units dedicated to producing medicines and vaccines.

Its operational structure includes research hubs, clinical development units, manufacturing sites, commercial subsidiaries and partnerships with governments and scientific institutions.

Key market factors affecting the company include pharmaceutical innovation cycles, global health regulations, the evolution of infectious diseases, government vaccination programs, competition among global laboratories, clinical development costs and macroeconomic conditions.

GlaxoSmithKline plc is listed on the New York Stock Exchange (NYSE) under the ticker GSK.

History and when GlaxoSmithKline plc was founded

GlaxoSmithKline plc was founded in 2000 in London, United Kingdom, through the merger of Glaxo Wellcome and SmithKline Beecham. Its creation combined two companies with long historical backgrounds in the pharmaceutical sector — some dating back to the 18th century — to integrate scientific capabilities, expand production scale and strengthen global competitiveness.

During the 2000s, GSK consolidated its global footprint, expanded investments in vaccines and strengthened its presence in emerging markets, while reorganizing research priorities to focus on high-potential scientific programs.

In the 2010s, the company pursued strategic deals, restructured its consumer-health operations and established partnerships with biotechnology firms to accelerate development of vaccines and innovative therapies.

From 2020 to 2024, GSK reinforced its vaccine-development efforts, realigned its strategic focus toward immunology, HIV and infectious diseases, and refined its corporate structure following the separation of its consumer-health division.

The period was marked by increased investment in scientific innovation and expanded strategic collaborations.

Additional Information

The Company GlaxoSmithKline PLC (United States), is listed on NYSE with a market value of $ 99.25 Billions, having an equity of $ 21.29 Billions.

With a total of 90.090 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 42.36 Billions, which generated a profit in the amount of $ 7.30 Billions.

As for its main indicators, the Company has a P/E ratio of 13.60, a P/BV ratio of 4.66 and in the last 12 months the dividend yield of GSK was at 3.35%.

The Company is traded internationally through the ticker GSK.

Market cap

$ 99.25 Billions

Net worth

$ 21.29 Billions

US$ 21,286,490,000.00

Assets

$ 82.89 Billions

US$ 82,890,540,000.00

Total Shares Outstanding

2.02 Billions

2,017,000,000

Average Daily Trading Volume

$ 4.47 Millions

US$ 4,465,832.00

Sector

Health

Industry

Pharmaceutical Products

GSK

GSK revenue and profits

Financial Results GSK

DRAG THE FRAME TO SEE MORE DATA

GSK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 80.60 82,67% (12M)

P/E

216.81

3.32%

ROE

0.64%

P/BV

1.39

CI - Cigna

$ 283.91 3,73% (12M)

P/E

12.08

2.16%

ROE

14.63%

P/BV

1.77

CNC - Centene

$ 46.92 --25,72% (12M)

P/E

-3.88

0.00%

ROE

-25.12%

P/BV

0.97

HUM - Humana

$ 277.57 5,33% (12M)

P/E

24.58

1.34%

ROE

6.95%

P/BV

1.71

SNY - Sanofi

$ 48.13 2,10% (12M)

P/E

10.49

4.59%

ROE

13.90%

P/BV

1.46

HCA - HCA Healthcare

$ 479.02 59,39% (12M)

P/E

17.28

0.61%

ROE

-293.84%

P/BV

-50.76

LLY - Eli Lilly

$ 1,085.19 36,89% (12M)

P/E

52.63

0.56%

ROE

77.20%

P/BV

40.63